P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings. (April 2023) - Hall, P.; Howell, S.; Venkitaraman, R.; Thomson, A.; Raja, F.; King, J.; Michie, C.; Khan, S.; Brunt, A.M.; Gahir, D.; McAdam, K.; Cooner, J.; et al.